Brief: Gen Ilac Says Salutem, Authorized by Gen Ilac, Wins State Supply Office Tenders, Drug Sales Via Salutem To Contribute 116.5 Mln Lira To Total Sales
07/07/2025 07:34
July 7 (Reuters) - GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET GENIL.IS: SALUTEM ECZA DEPOSU MEDIKAL (SALUTEM) WHICH AUTHORIZED BY GEN ILAC TO JOIN STATE SUPPLY OFFICE TENDERS AND OUR RELATED PARTY AT SAME TIME JOINED STATE SUPPLY OFFICE 2 AND 4 MONTHS TENDERS AS A RESULT OF TENDERS DRUGS WHICH WILL SUPPLIED BY SALUTEM ARE PROVIDED FROM GEN ILAC CONTRIBUTION OF DRUGS WHICH WILL BE SUPPLIED BY SALUTEM AS A RESULT OF STATE SUPPLY OFFICE 2 AND 4 MONTHS TENDERS TO THE OUR COMPANY'S TOTAL SALES WILL BE 116.5 MILLION LIRA Source text for Workspace: nIKA8l8pMQ Further company coverage: GENIL.IS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira